Solsence, Inc. (formerly Nanophase Technologies Corporation) rebranded on March 7, 2025, focusing on skin health innovation and consumer products. Total revenue increased to $62.06 million in 2025 from $52.35 million in 2024, primarily driven by consumer products. Consumer products revenue grew to $54.87 million (88% of total revenue) in 2025, up from $44.37 million (85%) in 2024. Net income significantly decreased to $1.79 million in 2025 from $4.24 million in 2024. Cash used in operating activities was ($8.57) million in 2025, a substantial shift from $1.97 million provided by operating activities in 2024. The company received $1.73 million from the Employee Retention Credit (ERC) program and $0.27 million in related interest in June 2025, recognizing $1.23 million ERC and $0.19 million interest income. Outstanding debt to related parties (Beachcorp, LLC and Strandler, LLC) increased significantly, with Beachcorp, LLC balances rising from $4.00 million in 2024 to $14.27 million in 2025. Jess Jankowski retired as CEO effective November 21, 2025, receiving $366,912 in severance and accelerated option vesting. Kevin Cureton was appointed President and CEO on September 3, 2025.